BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2361014)

  • 1. Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's disease.
    Hasegawa M; Arai T; Ihara Y
    Neuron; 1990 Jun; 4(6):909-18. PubMed ID: 2361014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistological study on brains of Alzheimer's disease using antibodies to fetal antigens, C-series gangliosides and microtubule-associated protein 5.
    Takahashi H; Hirokawa K; Ando S; Obata K
    Acta Neuropathol; 1991; 81(6):626-31. PubMed ID: 1909079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.
    Kondratick CM; Vandré DD
    J Neurochem; 1996 Dec; 67(6):2405-16. PubMed ID: 8931473
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recognition of Alzheimer paired helical filaments by monoclonal neurofilament antibodies is due to crossreaction with tau protein.
    Nukina N; Kosik KS; Selkoe DJ
    Proc Natl Acad Sci U S A; 1987 May; 84(10):3415-9. PubMed ID: 3106969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microtubule-associated proteins MAP5 and MAP1x: closely related components of the neuronal cytoskeleton with different cytoplasmic distributions in the developing brain.
    Garner CC; Matus A; Anderton B; Calvert R
    Brain Res Mol Brain Res; 1989 Jan; 5(1):85-92. PubMed ID: 2927285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A possible fetal antigen of Mr 70,000 in neurofibrillary tangles.
    Morishima-Kawashima M; Arai T; Ogawara M; Takio K; Titani K; Saitoh T; Kosik KS; Ihara Y
    Brain Res; 1991 Jul; 554(1-2):316-20. PubMed ID: 1933313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylated MAP1b, alias MAP5 and MAP1x, is involved in axonal growth and neuronal mitosis.
    Riederer BM; Moya F; Calvert R
    Neuroreport; 1993 Jun; 4(6):771-4. PubMed ID: 8347824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microtubule-associated protein 2: monoclonal antibodies demonstrate the selective incorporation of certain epitopes into Alzheimer neurofibrillary tangles.
    Kosik KS; Duffy LK; Dowling MM; Abraham C; McCluskey A; Selkoe DJ
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7941-5. PubMed ID: 6083566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two monoclonal antibodies recognize Alzheimer's neurofibrillary tangles, neurofilament, and microtubule-associated proteins.
    Ksiezak-Reding H; Yen SH
    J Neurochem; 1987 Feb; 48(2):455-62. PubMed ID: 2432180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal processing of multiple proteins in Alzheimer disease.
    Zhang H; Sternberger NH; Rubinstein LJ; Herman MM; Binder LI; Sternberger LA
    Proc Natl Acad Sci U S A; 1989 Oct; 86(20):8045-9. PubMed ID: 2813376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression of phosphorylated and non-phosphorylated forms of MAP5 in the amphibian CNS.
    Viereck C; Matus A
    Brain Res; 1990 Feb; 508(2):257-64. PubMed ID: 2306617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.
    Bancher C; Brunner C; Lassmann H; Budka H; Jellinger K; Wiche G; Seitelberger F; Grundke-Iqbal I; Iqbal K; Wisniewski HM
    Brain Res; 1989 Jan; 477(1-2):90-9. PubMed ID: 2495152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's disease.
    Geddes JW; Lundgren K; Kim YK
    J Neurosci Res; 1991 Sep; 30(1):183-91. PubMed ID: 1795403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tau in Alzheimer's disease and Down's syndrome is insoluble and abnormally phosphorylated.
    Hanger DP; Brion JP; Gallo JM; Cairns NJ; Luthert PJ; Anderton BH
    Biochem J; 1991 Apr; 275 ( Pt 1)(Pt 1):99-104. PubMed ID: 1826835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease.
    Augustinack JC; Schneider A; Mandelkow EM; Hyman BT
    Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurofibrillary tangles in Alzheimer's disease and progressive supranuclear palsy: antigenic similarities and differences. Microtubule-associated protein tau antigenicity is prominent in all types of tangles.
    Bancher C; Lassmann H; Budka H; Grundke-Iqbal I; Iqbal K; Wiche G; Seitelberger F; Wisniewski HM
    Acta Neuropathol; 1987; 74(1):39-46. PubMed ID: 2444063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MAP5: a novel brain microtubule-associated protein under strong developmental regulation.
    Riederer B; Cohen R; Matus A
    J Neurocytol; 1986 Dec; 15(6):763-75. PubMed ID: 3819779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurofibrillary tangles and the neuronal cytoskeleton.
    Anderton BH; Brion JP; Flament-Durand J; Haugh MC; Kahn J; Miller CC; Probst A; Ulrich J
    J Neural Transm Suppl; 1987; 24():191-6. PubMed ID: 3119774
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Up-regulation of phosphorylated/activated p70 S6 kinase and its relationship to neurofibrillary pathology in Alzheimer's disease.
    An WL; Cowburn RF; Li L; Braak H; Alafuzoff I; Iqbal K; Iqbal IG; Winblad B; Pei JJ
    Am J Pathol; 2003 Aug; 163(2):591-607. PubMed ID: 12875979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MAP5 in cultured hippocampal neurons: expression diminishes with time and growth cones are not immunostained.
    Denny JB
    J Neurocytol; 1991 Aug; 20(8):627-36. PubMed ID: 1940978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.